phlebitis. Adjustment and management of vascular access device
Conditions
Interventions
Intervention 1: In the intervention group after putting a new catheter, 5 × 5 cm sterile gauze is placed in the place of catheter and then will be fixed by leucoplast. If we made a mistake to put the
Treatment - Drugs
Placebo
In the intervention group after putting a new catheter, 5 × 5 cm sterile gauze is placed in the place of catheter and then will be fixed by leucoplast. If we made a mistake to put the catheter more th
In the control group after putting a new catheter the place will be fixed only by Leucoplast (Which typically used in Iran’s/Kermanshah’s hospitals now). In this group, like intervention group, if we
Sponsors
Kermanshah University of Medical Sciences, Vice – Chancellery of Research & Technology Affairs
Eligibility
Sex/Gender
All
Age
20 Years to 90 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Having serum or IV medicine; Having no sensitivity to Leucoplast, Iodine or other medicines; Having no blood transfusion; having normal skin in the site that insert intravenous catheter; having no IV infusion of Hypertonic serum, having Systolic blood pressure upper 90 mm/Hg. Exclusion criteria: The patient discharging or expiring, before 72 hours insert intravenous catheter
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of phlebitis. Timepoint: 24,48,72 hourse after catheter placement. Method of measurement: phlebitis scale.;Intensity of phlebitis. Timepoint: 24,48,72 hourse after catheter placement. Method of measurement: phlebitis scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactF.Hadadian chaqayy
Kermanshah University of Medical Sciences
Outcome results
None listed